Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by John Branston
  • October 7, 2016
  • Articles

Conference Live: Evaluating the impact of your medical congress presence…more cost effectively

Conference Live: Evaluating the impact of your medical congress presence…more cost effectively

It’s conference season again! My two favourite seasons of the year!
Organising a company’s presence, not just logistically, but in terms of delivering key information, data and messages, is a massive part of some people’s workload at this time of year. More and more people are also being asked to demonstrate the effect that congress presence is having on brand and company perception, or on patterns of thought with regard to how treatment is going to evolve.

read more »

Conducting mobile conference research

Our digital expert, Director John Branston explores how a mobile approach offers a better way of evaluating the impact of your conference presence

Pharmaceutical companies spend significant time and investment on marketing at medical conferences. Effective evaluation of the success of the event is essential to conference organisers wishing to get an understanding of their return on investment. In this video, John discusses the importance of developing a mobile approach to gain a better understanding of how your presence at conference has been perceived by your target customers. 

Click here to find out more about our mobile approach for conducting conference research »
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here » 
 

read more »

How a mobile methodology elicited a deeper understanding of the key drivers behind physicians’ prescribing decisions

After the recent launch of a competitor drug in cardiology, our client wanted to better understand the degree of differentiation between products, focusing especially on the way physicians justified their selection of specific novel products which are known to be poorly differentiated.

In addition, a better understanding of the overall justification for prescribing novel therapies (versus standard-of-care) was required.

read more »

  • Posted by Olivia Richardson
  • June 29, 2012
  • Awards, News

An Award-Winning Conference

An Award-Winning Conference

The Research Partnership had a very successful EphMRA Conference in Paris this year.

We are proud to announce that our Director John Branston and co-presenter Martin Lange of Merck Serono were awarded the prestigious Jack Hayhurst Award for Best Paper for "Rx Rationale: Physician Research via an iPhone App".John and Martin’s paper explored the potential of using smartphone Apps as a platform for collecting detailed qualitative insights into physicians' decision rationale at the moment of prescription. Current statistics around mobile technology reveal that many physicians are now using iPhone, iPads and other mobile devices to assist them in their daily practices. Merck Serono and The Research Partnership’s paper used the findings from a study using mobile research technology in order to demonstrate how this methodology gives access to individual physicians’ thinking at the exact point when the decision to prescribe a brand is taken.Delegates rated the paper highest out of all the papers given at the conference in Paris this year.Commenting on receiving the award, Director John Branston said, “Digital and mobile research techniques have become a strong interest of mine and I was delighted to be able to work with Merck Serono on a project which would explore the benefits and challenges of mobile research in a real-life marketing context. We found…

read more »

  • Posted by Olivia Richardson
  • June 1, 2012
  • Events

EphMRA Conference 2012

EphMRA Conference 2012

Paris, France June 19-21, 2012

The Research Partnership attended and exhibited at the EphMRA 2012 conference from 19-21 June. Representing the company were Angela Duffy, Senior Director; John Branston and Richard Head, Directors.The conference was well attended and opened with a thought-provoking discussion session looking at how the cost/benefit evaluation of treatments could be evaluated from a health economics standpoint. Other noteworthy papers at the event looked at the growing impact of social and digital media within market research, as well as the “gamification” of research, which formed the basis for many conversations in the breaks and at the agency fair.The conference ended on a high for The Research Partnership as John Branston, along with Martin Lange of Merck Serono, were awarded the prestigious Jack Hayhurst Best Paper award for their presentation “Rx Rationale: Physician research via an iPhone app”, which explored the potential of using smartphone Apps as a platform for collecting detailed qualitative insights into physicians' decision rationale at the moment of prescription. Angela Duffy was also delighted to be nominated runner up in the ‘Contribution to Pharmaceutical Market Research’ award.For more information on the paper please click here. Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our…

read more »